Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (131-140 of 373) with videos related to

Pageof 38
Sort By:
Plos One|April 14, 2010
Association between DNA damage response and repair genes and risk of invasive serous ovarian cancerJoellen M Schildkraut, Edwin S Iversen, Melanie A Wilson, et al.
Molecular Oncology|April 23, 2009
Role of genetic polymorphisms and ovarian cancer susceptibilityPeter A Fasching, Simon Gayther, Leigh Pearce, et al.
Gynecologic Oncology|March 4, 2014
Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patientsChelsea Zhang, Laura J Havrilesky, Gloria Broadwater, et al.
Frontiers in Oncology|July 12, 2012
Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial CancerJay E Allard, Gadisetti V R Chandramouli, Katherine Stagliano, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroupJoellen M Schildkraut, Patricia G Moorman, Amy E Bland, et al.
Journal of the Society for Gynecologic Investigation|May 16, 2006
The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancerMonica Brown Jones, Aletta P Houwink, Brandi K Freeman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 13, 2017
Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial CancerBrittany A Davidson, Jessie Ehrisman, Sara Abbott, et al.
Cancer|November 11, 2011
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancerAngeles Alvarez Secord, Andrew Berchuck, Robert V Higgins, et al.
American Journal of Epidemiology|October 31, 2024
Healthcare Access Domains and Treatment as Mediators of Ovarian Cancer Racial Disparities in Survival: A Structural Equation Modeling Analysis in SEER-MedicareClare Meernik, Quan Chen, Lauren E Wilson, et al.
JAMA Network Open|February 1, 2023
Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist ConsultationAnjali Gupta, Quan Chen, Lauren E Wilson, et al.
Pageof 38

Showing results (131-140 of 373) with videos related to

Sort By:
Pageof 38
Plos One|April 14, 2010
Association between DNA damage response and repair genes and risk of invasive serous ovarian cancerJoellen M Schildkraut, Edwin S Iversen, Melanie A Wilson, et al.
Molecular Oncology|April 23, 2009
Role of genetic polymorphisms and ovarian cancer susceptibilityPeter A Fasching, Simon Gayther, Leigh Pearce, et al.
Gynecologic Oncology|March 4, 2014
Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patientsChelsea Zhang, Laura J Havrilesky, Gloria Broadwater, et al.
Frontiers in Oncology|July 12, 2012
Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial CancerJay E Allard, Gadisetti V R Chandramouli, Katherine Stagliano, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroupJoellen M Schildkraut, Patricia G Moorman, Amy E Bland, et al.
Journal of the Society for Gynecologic Investigation|May 16, 2006
The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancerMonica Brown Jones, Aletta P Houwink, Brandi K Freeman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 13, 2017
Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial CancerBrittany A Davidson, Jessie Ehrisman, Sara Abbott, et al.
Cancer|November 11, 2011
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancerAngeles Alvarez Secord, Andrew Berchuck, Robert V Higgins, et al.
American Journal of Epidemiology|October 31, 2024
Healthcare Access Domains and Treatment as Mediators of Ovarian Cancer Racial Disparities in Survival: A Structural Equation Modeling Analysis in SEER-MedicareClare Meernik, Quan Chen, Lauren E Wilson, et al.
JAMA Network Open|February 1, 2023
Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist ConsultationAnjali Gupta, Quan Chen, Lauren E Wilson, et al.
Pageof 38